Life Sciences BC Announces 2022 Graduates of Investor Readiness Program
VANCOUVER, British Columbia – Life Sciences British Columbia (LSBC) is proud to announce the graduating companies from its annual Investor Readiness Program (IRP), which runs from September to March and pairs early-stage BC small and medium-sized enterprises (SMEs) with Entrepreneurs in Residence (EIRs) to become investor-ready. The 2022 IRP graduating group is comprised of: 4M BioTech, Apricell Biotechnology Inc., Eyam Vaccines and Immunotherapeutics Ltd, HTuO Biosciences, L9 BioScience Inc., ORX Surgical, Rostrum Medical Innovations, Total Flow Medical, and VoxCell BioInnovation.
“Congratulations to the graduating companies of the Life Sciences BC Investor Readiness Program! A big thank you also to our esteemed EIRs, who brought this year’s program to life through dedication, mentorship, and sharing their expertise,” said Wendy Hurlburt, President and CEO of LSBC.
This year’s EIRs included mentorship from the following individuals:
- Ardakani, Ali – Novateur Ventures;
- Frohlich, Tom – Chinook Therapeutics;
- Harrison, Nancy – Amplitude Ventures;
- Helliwell, David – Thrive Health;
- Irwin, Brenda – Relentless Venture Fund;
- Kendall, Malcolm – Microbiome Insights;
- Madani Hermann, Betsabeh – Lifesciences and Digital Health;
- Mercer, Sam – Samuel Mercer Consulting;
- Robertson, Jason – Nimbus Synergies; and
- Sebestyen, Norma – Independent Consultant.
The Investor Readiness Program is designed around individual coaching and complemented by educational sessions, goal setting, peer-to-peer feedback, conference opportunities and group meetings. The program draws upon the expertise and acumen of experienced life science professionals to focus specifically on investor readiness of early-stage life sciences SMEs.
After six months of development, the program culminates with an investor pitch session where participants use their new skills to pitch to a group of pre-qualified investors.
For more details about the 2023 program, please contact William Burrows, Director, Business Operations & Programs.
About Life Sciences BC
Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and promotion of our world-class science and industry.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, Life Sciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.
About the BC life sciences sector
BC is home to the fastest growing life sciences sector in Canada and our reputation is global. Vancouver was recently named the 2021 top life sciences start up ecosystem in Canada. Startup Genome ranked Vancouver 21 out of 280 global ecosystems, listing it as the only Canadian city in the top 25.
BC life sciences exceed Canada’s life sciences GDP growth (2018 data) and employ more than 18,000 employees (2020 data) at above-average salaries. During 2020, BC biotech companies more than doubled revenue from the top four deals compared to 2019.